WO1995007090A1 - Probiotics - Google Patents
Probiotics Download PDFInfo
- Publication number
- WO1995007090A1 WO1995007090A1 PCT/GB1994/001849 GB9401849W WO9507090A1 WO 1995007090 A1 WO1995007090 A1 WO 1995007090A1 GB 9401849 W GB9401849 W GB 9401849W WO 9507090 A1 WO9507090 A1 WO 9507090A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lactobacillus
- composition
- pigs
- probiotic
- suckling
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
Definitions
- THIS INVENTION relates to probiotics. In animal husbandry it is commonly desired that newly born animals should gain weight rapidly, usually with a view to early slaughter.
- European Patent 203,586 It is proposed in European Patent 203,586 to administer a strain of the species Lactobacillus fermentum to animals such as pigs, cows, sheep, goats and horses in order to prevent gastrointestinal disease.
- the use of a strain of Lactobacillus lactis is proposed in US Patent 3,953,609 and the use of a mixture of Lactobacillus acidophilus and non pathogenic E.coli is disclosed in US Patent 3,320,130.
- Other strains of Lactobacillus are disclosed for treating infectious disease in US Patent 4,314,995. The above and other references are discussed in European Patent 203,586.
- Lactobaci1lus delbrueckii has particularly beneficial characteristics in such applications, especially as regards piglets and particularly when used together with Lactobacillus acidophilus and preferably also with Lactobacillus fermentum and that the piglet is preferably fed with compositions comprising such microorganisms both during the suckling and in the post suckling stage.
- post suckling is meant the stage by which the piglet is able to obtain most of its nutritional intake from sources other than milk, and preferably a stage by which it no longer consumes mother's milk.
- the invention involves a process of increasing the growth rate of pigs which comprises conditioning their digestive tracts by administrating to them, preferably both in the suckling and in a post suckling stage a biologically pure culture of Lactobacillus delbrueckii in an orally and digestively acceptable composition optionally formed by admixture of such a culture with at least one other substance.
- the culture may comprise a nutritionally acceptable carrier which may be water, a food for example milk or a milk product or starch and/or other materials for example adjuvants, lubricants or carriers .
- Other substances with which it is preferably admixed include biologically pure cultures of Lactobaci1lus acidophilus and preferably also Lactobacillus fermentum.
- digestively acceptable is meant capable of oral administration without detriment to the digestive system.
- the invention also comprises a digestively acceptable composition for conditioning the digestive system of pigs formed by admixture of a biologically pure culture of Lactobacillus delbrueckii with a biologically pure culture of Lactobacillus acidophilus and Lac obaci1lus fermentum, preferably together with milk, a milk product and/or starch.
- the composition may be allowed to ferment before use if desired.
- the composition conditions the intestines.
- the invention also comprises a process of making a composition as aforesaid by admixture of the said ingredients and optionally subsequently fermentating the composition.
- a probiotic preparation which consists of 3 selected lactobacilli, deposited at the National Collections of Industrial and Marine Bacteria Limited, 23 Machar Drive, Aberdeen AB2 1RY Scotland UK on 2 April 1990 namely Lactobacillus fermentum (L94) NCIMB 30016, Lactobacillus delbrueckii (L99) NCIMB 30017 and Lactobacillus acidophilus (L83) NCIMB 30015 which are produced separately by fermentation and freeze drying was produced by mixing the lactobacilli in the correct proportion to provide viable cells of the specified colony forming units per gram (cfu/g) of product.
- the deposits are subject to the terms of the Budapest Treaty Fermentation
- the lactobacilli were produced separately by growing each of them in a 30L batch fermenter by the following procedure.
- the temperature was adjusted to 30°C and the pH to 6.0.
- the fermenter was run aerobically for L94 and L83 and anaerobically for L99 and harvesting the lactobacilli when growth was complete. Harvesting consisted of centrifuging the cells and freeze drying the cells.
- ADMINISTRATION OF THE PROBIOTIC LACTOBACILLI TO PIGLETS Product administered in the suckling period The product was administered to the piglets as an oral dose as soon as possible after birth and periodically during the suckling period, e.g. 0 and 14 days and on the day of weaning.
- the drench took the form of a mixture of the 3 lactobacilli as a freeze dried powder mixed with water, or with sufficient phosphate buffer saline solution (PBS) in quantities to administer to at least one litter.
- PBS phosphate buffer saline solution
- the dose aimed for was 3 x 10 9 cfu of each lactobacillus per piglet/dose.
- the control piglets were dosed with the corresponding liquid, ie water or PBS.
- the mixture of freeze dried Lactobacilli were mixed with skimmed milk powder (SMP) in a ratio to supply the necessary quantities in the feed.
- the calculated quantity administered in the feed was approximately 1 x 10 s cfu per pig per day of each lactobacillus over the 4 week post weaned period.
- the probiotic mixture was administered as a top dressing to the feed pellets, put into the feed hopper or mixed directly into the weaner feed.
- Lactobacillus species/dose suspension of the probiotic lactobacilli and the control pigs were dosed with water.
- the probiotic powder was sprinkled onto the feed daily and the corresponding SMP carrier was sprinkled onto the feed of the control pigs.
- EXAMPLE 2 Design Forty-eight hybrid sows mated to conventional sires were randomly assigned pre-farrowing to control or treatment.
- the treatment litters were orally dosed with 3ml of 2 of the lactobacilli L. fermentum and L. delbrueckii.
- the control litters were dosed with distilled water.
- the treated piglets were dosed with 3ml of a suspension of the 2 lactobacilli in quarter strength Ringers solution.
- Control pigs were dosed with 3ml quarter strength Ringers solution.
- Each 3ml dose provided 1 x 10 9 of each Lactobacillus species.
- Post Weaning After weaning the pigs were penned in groups of approximately 20 according to the treatments in the suckling period. No probiotic treatment was given in this period. All the pigs were fed a standard commercial pelleted rearing diet.
- Sows and pigs were subjected to normal husbandry procedures. Creep feed was not given during the suckling period.
- the piglets were orally dosed on days 1, 14, and the day of weaning. At weaning the pigs were transferred to commercial weaner pens holding approx 20 pigs/pen.
- This experiment was designed as an E.coli challenge experiment on very early weaned piglets rather than as a growth experiment.
- the challenging E.coli failed to induce a pathogenic response.
- the pigs were weighed at relevant times and the effect of the probiotic on growth performance was assessed.
- the objective of the original design was to administer the probiotic daily to piglets from birth, challenge with E.coli K88 once on a day prior to weaning and assess the protective effect of the probiotic against scours caused by the E.coli.
- Experimental Piglets from paired sows were earmarked for treatment or control probiotic dosing from birth and every other day thereafter.
- the treatment dose consisted of the three lactobacilli L94, L99, L83 delivered in 2ml to supply 1-10 9 of each lactobacilli. Additional doses were given on the day before and after weaning on day 14. (The E.coli was given on day 7) .
- the pigs were weaned into individual cages. Health status was checked daily and they were also weighed daily. Results
- the growth data indicated that even in a situation where there is no health problem a growth performance improvement is observed.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Probiotics for pigs contain Lactobacillus delbrueckii; they are preferably fed during the suckling and post suckling stages.
Description
PROBIOTICS
THIS INVENTION relates to probiotics. In animal husbandry it is commonly desired that newly born animals should gain weight rapidly, usually with a view to early slaughter.
It is proposed in European Patent 203,586 to administer a strain of the species Lactobacillus fermentum to animals such as pigs, cows, sheep, goats and horses in order to prevent gastrointestinal disease. The use of a strain of Lactobacillus lactis is proposed in US Patent 3,953,609 and the use of a mixture of Lactobacillus acidophilus and non pathogenic E.coli is disclosed in US Patent 3,320,130. Other strains of Lactobacillus are disclosed for treating infectious disease in US Patent 4,314,995. The above and other references are discussed in European Patent 203,586. The use in humans of certain strains of Lactobacillus acidophilus is disclosed in European Patent 199,535, and the use of species of Lactobacillus and other microorganisms is disclosed in the treatment of animals in European Patent 271,364. It is proposed to administer probiotics to animals prior to weaning in patent application WO 93/00012.
We have found that the use of Lactobaci1lus delbrueckii has particularly beneficial characteristics in such applications, especially as regards piglets and particularly when used together with Lactobacillus acidophilus and preferably also with Lactobacillus fermentum and that the piglet is preferably fed with compositions comprising such microorganisms both during the suckling and in the post suckling stage. By "post
suckling" is meant the stage by which the piglet is able to obtain most of its nutritional intake from sources other than milk, and preferably a stage by which it no longer consumes mother's milk. The invention involves a process of increasing the growth rate of pigs which comprises conditioning their digestive tracts by administrating to them, preferably both in the suckling and in a post suckling stage a biologically pure culture of Lactobacillus delbrueckii in an orally and digestively acceptable composition optionally formed by admixture of such a culture with at least one other substance. The culture may comprise a nutritionally acceptable carrier which may be water, a food for example milk or a milk product or starch and/or other materials for example adjuvants, lubricants or carriers .
Other substances with which it is preferably admixed include biologically pure cultures of Lactobaci1lus acidophilus and preferably also Lactobacillus fermentum. By "digestively acceptable" is meant capable of oral administration without detriment to the digestive system.
The invention also comprises a digestively acceptable composition for conditioning the digestive system of pigs formed by admixture of a biologically pure culture of Lactobacillus delbrueckii with a biologically pure culture of Lactobacillus acidophilus and Lac obaci1lus fermentum, preferably together with milk, a milk product and/or starch. The composition may be allowed to ferment before use if desired. The composition conditions the intestines.
The invention also comprises a process of making a
composition as aforesaid by admixture of the said ingredients and optionally subsequently fermentating the composition.
EXAMPLES A probiotic preparation which consists of 3 selected lactobacilli, deposited at the National Collections of Industrial and Marine Bacteria Limited, 23 Machar Drive, Aberdeen AB2 1RY Scotland UK on 2 April 1990 namely Lactobacillus fermentum (L94) NCIMB 30016, Lactobacillus delbrueckii (L99) NCIMB 30017 and Lactobacillus acidophilus (L83) NCIMB 30015 which are produced separately by fermentation and freeze drying was produced by mixing the lactobacilli in the correct proportion to provide viable cells of the specified colony forming units per gram (cfu/g) of product. The deposits are subject to the terms of the Budapest Treaty Fermentation
The lactobacilli were produced separately by growing each of them in a 30L batch fermenter by the following procedure.
1 An inoculant freeze dried culture was grown up on 200-400ml of MRS broth at 37°C to provide a rich culture overnight.
2 The 30L fermenter was charged with the following and sterilised at 121°C for 30 min: yeast autolysate 30g/L
MgS04.7 H20 0.21g/L
MnS04.4H20 O.Q5g/L
"Tween" 80 Surfactant 1.0 ml/L "Silcolapse" 5000 foam suppressant 2.0 ml/L
H3P04 (17 Molar) • 1.0 ml/L
Sterilised Glucose to give 50-100g/L
The temperature was adjusted to 30°C and the pH to 6.0. The fermenter was run aerobically for L94 and L83 and anaerobically for L99 and harvesting the lactobacilli when growth was complete. Harvesting consisted of centrifuging the cells and freeze drying the cells. ADMINISTRATION OF THE PROBIOTIC LACTOBACILLI TO PIGLETS Product administered in the suckling period The product was administered to the piglets as an oral dose as soon as possible after birth and periodically during the suckling period, e.g. 0 and 14 days and on the day of weaning. The drench took the form of a mixture of the 3 lactobacilli as a freeze dried powder mixed with water, or with sufficient phosphate buffer saline solution (PBS) in quantities to administer to at least one litter.
The dose aimed for was 3 x 109 cfu of each lactobacillus per piglet/dose. The control piglets were dosed with the corresponding liquid, ie water or PBS.
Product administered in the post weaned period
The mixture of freeze dried Lactobacilli were mixed with skimmed milk powder (SMP) in a ratio to supply the necessary quantities in the feed. The calculated quantity administered in the feed was approximately 1 x 10s cfu per pig per day of each lactobacillus over the 4 week post weaned period.
The probiotic mixture was administered as a top dressing to the feed pellets, put into the feed hopper or mixed directly into the weaner feed.
EXAMPLES OF THE EFFECT OF ADMINISTERING THE 3
LACTOBACILLI TO PIGLETS
EXAMPLE 1
Design Thirty two Landrace/Large White sows were paired according to genotype, parity and service data and reared and fed according to the standard procedure of the unit during the pregnancy period. At farrowing the sows were randomly assigned to farrowing accommodation so that litters destined to become control or test litters were assigned to accommodation so that probiotic lactobacilli could not be inadvertently transferred from test to control piglets through piglet contact or via the pigman.
Treatments - Lactation Period The treated pigs were dosed with 3 ml (109 of each
Lactobacillus species/dose) suspension of the probiotic lactobacilli and the control pigs were dosed with water.
Post Weaning Period
The probiotic powder was sprinkled onto the feed daily and the corresponding SMP carrier was sprinkled onto the feed of the control pigs.
Experimental
During the first few days piglets were fostered between litters before dosing or within treatment groups after dosing.
Normal husbandry practices were adopted throughout the experiment. Creep feed was not provided. Litters were checked daily for signs of ill health. The pigs were weaned at 25 days of age. At weaning the pigs were weighed individually and approximately half from each treatment allocated
randomly, within treatment, to rearing pens at 8-10 pigs/pen. Water and feed were provided ad libitum.
Results
Suckling Period: There was no difference between treatments for: the number of pigs born or weaned per litter; the health status of the piglets.
There was a 7.5% increase in daily liveweight gain of the probiotic treated piglets. Post Weaned Period
There was a 17% improvement (P<0.05) in liveweight gain and feed intake by the pigs given the probiotic.
(Table 1) .
When covariate corrections for group size were taken into account there was a 25% improvement in these parameters.
Table 1 - Growth Performance in the Post Weaned Period
Sucking Period Control Probiotic
Litter size at birth 11.6 11.3
Litter size at weaning 10.3 9.3 Piglet weight at birth (Kg) 1.56 1.49
Piglet weight at weaning (Kg) 6.87 7.15
Piglet liveweight gain (g/day) 212 228
Weaned Period
Group Size 10.9 8.7 Age at weaning (days) 23.0 22.4
Initial weight (Kg) 6.53 6.45
Pig liveweight gain (g/day) 313 365
Feed Intake (g/day) 470 553
Covariate Correction for Group Si Lzzee Pig liveweight gain (g/day 301 377
Feed intake (g/day) 465 558
CONCLUSION
There was an increase in liveweight gain in the suckling period when there was no background disease in evidence. There was a significant liveweight gain and feed intake increase in the post weaned period when the probiotic was administered in both the suckling and the post weaned period.
EXAMPLE 2 Design Forty-eight hybrid sows mated to conventional sires were randomly assigned pre-farrowing to control or treatment. The treatment litters were orally dosed with 3ml of 2 of the lactobacilli L. fermentum and L. delbrueckii. The control litters were dosed with distilled water.
Litter numbers were approximated to 10/litter by cross-fostering. Treatments : Lactation Period
The treated piglets were dosed with 3ml of a suspension of the 2 lactobacilli in quarter strength Ringers solution. Control pigs were dosed with 3ml quarter strength Ringers solution. Each 3ml dose provided 1 x 109 of each Lactobacillus species. Post Weaning After weaning the pigs were penned in groups of approximately 20 according to the treatments in the suckling period. No probiotic treatment was given in this period. All the pigs were fed a standard commercial pelleted rearing diet. Experimental
Sows and pigs were subjected to normal husbandry
procedures. Creep feed was not given during the suckling period.
The piglets were orally dosed on days 1, 14, and the day of weaning. At weaning the pigs were transferred to commercial weaner pens holding approx 20 pigs/pen.
Individual pig weights were measured at weaning and at 4 weeks post weaning. The feeding system in the post weaning period did not allow for accurate measurement of feed intake. Two batches of pigs were weaned and put through the post weaning unit. Results In the Suckling Period there were no health problems in either of the control or treatment pigs; there was no effect of the probiotic on the number weaned or on the growth rate to weaning. In the Post Weaned Period (Table 2):
Two batches of piglets, consisting in total of 400 pigs from both suckled probiotic and suckled control pigs were fed a standard pig rearer diet in the post weaned period.
The pigs which were probiotic dosed in the suckling period gained 3.5% more liveweight in the post weaned period than the control pigs. Table 2 - Growth Performance in the Post Weaned Period
Control Probiotic Pigs initial weight (Kg) 6.51 6.44
Pigs final weight (Kg) 19.40 19.59
Mean liveweight gain (g/day) 345 357 There were no differences between treatments in terms of health status of the pigs.
EXAMPLE 3
This experiment was designed as an E.coli challenge experiment on very early weaned piglets rather than as a growth experiment. The challenging E.coli failed to induce a pathogenic response. However, the pigs were weighed at relevant times and the effect of the probiotic on growth performance was assessed.
Design
The objective of the original design was to administer the probiotic daily to piglets from birth, challenge with E.coli K88 once on a day prior to weaning and assess the protective effect of the probiotic against scours caused by the E.coli. Experimental Piglets from paired sows were earmarked for treatment or control probiotic dosing from birth and every other day thereafter. The treatment dose consisted of the three lactobacilli L94, L99, L83 delivered in 2ml to supply 1-109 of each lactobacilli. Additional doses were given on the day before and after weaning on day 14. (The E.coli was given on day 7) .
The pigs were weaned into individual cages. Health status was checked daily and they were also weighed daily. Results
None of the pigs scoured. One of the pigs on the probiotic treatment died 8 days post weaning. This pig had performed badly from the start and was omitted from the growth performance calculations. In the suckling period there was no effect of the probiotic on growth. In the post weaned period the daily
liveweight gain was increased by 5%, feed intake was reduced by 3%, and feed conversion improved by 7% (Table 2) .
Table 3 - Growth Performance in the Post Weaned Period Control Probiotic
Pigs initial weight (Kg) 4.53 4.55
Final weight (Kg) 8.45 8.82
Food intake (g/day) 265 256
Weight gain (g/day) 210 221 Feed conversion ratio 1.33 1.16
Conclusion
The growth data indicated that even in a situation where there is no health problem a growth performance improvement is observed.
Claims
1 A process of growing pigs in which their growth rate is increased which comprises conditioning their digestive tracts by administering to them a digestively acceptable composition obtained from a biologically pure culture of Lactobacillus delbrueckii.
2 A process as claimed in Claim 1 in which the composition comprises a nutritionally acceptable carrier.
3 A process as claimed in Claim 2 in which the nutritionally acceptable carrier comprises water.
4 A process as claimed in any preceding claim in which the composition comprises a pH buffer.
5 A process as claimed in Claim 1 or 2 in which the composition is derived from biologically pure cultures of Lactobacillus delbrueckii and Lactobacillus acidophilus.
6 A process as claimed in any preceding claim in which the composition is administered to piglets in their suckling and post suckling stages.
7 A process as claimed in any preceding claim in which the composition is derived from biologically pure cultures of Lactobacillus delbrueukii, Lactobacillus acidophilus and Lactobacillus fermentum.
8 A digestively acceptable probiotic composition formed by mixing biologically pure cultures of Lactobacillus delbrueckii, Lactobacillus acidophilus and Lactobacillus fermentum.
9 A composition according to Claim 8 which comprises milk, a milk product and/or starch.
A composition according to Claim 8 or 9 which comprises a buffer. A composition according to Claims 8, 9 or 10 which has fermented. A process for preparing a probiotic which comprises mixing biologically pure cultures of Lactobacillus delbrueckii, Lactobacillus acidophilus and Lactobacillus fermentum to form a digestively acceptable composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU74657/94A AU7465794A (en) | 1993-09-06 | 1994-08-24 | Probiotics |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939318439A GB9318439D0 (en) | 1993-09-06 | 1993-09-06 | Probiotics |
GB9318439.8 | 1993-09-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995007090A1 true WO1995007090A1 (en) | 1995-03-16 |
Family
ID=10741575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1994/001849 WO1995007090A1 (en) | 1993-09-06 | 1994-08-24 | Probiotics |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7465794A (en) |
GB (1) | GB9318439D0 (en) |
WO (1) | WO1995007090A1 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008064893A1 (en) * | 2006-12-01 | 2008-06-05 | Organobalance Gmbh | Compositions, kits and uses for protecting the skin against pathogenic microorganisms |
US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
US7906112B2 (en) | 2003-12-19 | 2011-03-15 | The Procter & Gamble Company | Canine probiotic Lactobacilli |
US7998473B2 (en) | 2003-12-19 | 2011-08-16 | The Procter & Gamble Company | Methods of treatment or prevention of gastrointestinal disorders using canine probiotic bifidobacterium |
US8034601B2 (en) | 2005-05-31 | 2011-10-11 | The Procter & Gamble Company | Feline probiotic bifidobacteria |
US8563522B2 (en) | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
US8691303B2 (en) | 2009-07-31 | 2014-04-08 | The Iams Company | Dusted animal food |
US8809035B2 (en) | 2003-12-19 | 2014-08-19 | The Iams Company | Canine probiotic Bifidobacterium |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US9173423B2 (en) | 2009-07-31 | 2015-11-03 | The Iams Company | Animal food kibble with electrostatically adhered dusting |
US9192177B2 (en) | 2005-05-31 | 2015-11-24 | The Iams Company | Feline probiotic Lactobacilli |
US9210945B2 (en) | 2009-07-31 | 2015-12-15 | The Iams Company | Animal food having low water activity |
US9415083B2 (en) | 2004-05-10 | 2016-08-16 | Mars, Incorporated | Method for decreasing inflammation and stress in a mammal |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
US11154077B2 (en) | 2009-07-31 | 2021-10-26 | Mars, Incorporated | Process for dusting animal food |
US11304428B2 (en) | 2015-02-16 | 2022-04-19 | Mars, Incorporated | Interlocking kibble |
US11388914B2 (en) | 2015-04-28 | 2022-07-19 | Mars, Incorporated | Process of preparing a wet pet food, wet pet food produced by the process and uses thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN698495A0 (en) * | 1995-12-06 | 1996-01-04 | Pharma Pacific Pty Ltd | Improved therapeutic formulation and method |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3410771A1 (en) * | 1983-03-29 | 1985-05-23 | Mitsui Toatsu Chemicals, Inc., Tokio/Tokyo | ANIMAL FEED ADDITIVE, FOOD AND MICROORGANISM USED IN IT |
EP0221520A2 (en) * | 1985-10-31 | 1987-05-13 | Morinaga Milk Industry Co., Ltd. | A composition of feedstuff |
EP0281091A2 (en) * | 1987-03-06 | 1988-09-07 | Hoechst Aktiengesellschaft | Agents containing Bacillus polymyxa to deliver to animals |
DE3728702A1 (en) * | 1987-08-28 | 1989-03-09 | Bayer Ag | Organic chemical compound, microbiological process for its preparation, and its use |
WO1989005849A1 (en) * | 1987-12-23 | 1989-06-29 | Chr. Hansen's Laboratorium A/S | Lactic acid bacteria for use in fermented milk products and veterinary compositions |
EP0555618A2 (en) * | 1992-02-10 | 1993-08-18 | Renata Maria Anna Cavaliere Vesely | Dietetic and/or pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use |
-
1993
- 1993-09-06 GB GB939318439A patent/GB9318439D0/en active Pending
-
1994
- 1994-08-24 AU AU74657/94A patent/AU7465794A/en not_active Abandoned
- 1994-08-24 WO PCT/GB1994/001849 patent/WO1995007090A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3410771A1 (en) * | 1983-03-29 | 1985-05-23 | Mitsui Toatsu Chemicals, Inc., Tokio/Tokyo | ANIMAL FEED ADDITIVE, FOOD AND MICROORGANISM USED IN IT |
EP0221520A2 (en) * | 1985-10-31 | 1987-05-13 | Morinaga Milk Industry Co., Ltd. | A composition of feedstuff |
EP0281091A2 (en) * | 1987-03-06 | 1988-09-07 | Hoechst Aktiengesellschaft | Agents containing Bacillus polymyxa to deliver to animals |
DE3728702A1 (en) * | 1987-08-28 | 1989-03-09 | Bayer Ag | Organic chemical compound, microbiological process for its preparation, and its use |
WO1989005849A1 (en) * | 1987-12-23 | 1989-06-29 | Chr. Hansen's Laboratorium A/S | Lactic acid bacteria for use in fermented milk products and veterinary compositions |
EP0555618A2 (en) * | 1992-02-10 | 1993-08-18 | Renata Maria Anna Cavaliere Vesely | Dietetic and/or pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use |
Non-Patent Citations (2)
Title |
---|
CHEMICAL ABSTRACTS, Columbus, Ohio, US; * |
PATENT ABSTRACTS OF JAPAN * |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8563522B2 (en) | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
US8900568B2 (en) | 2003-12-19 | 2014-12-02 | The Iams Company | Method of treating diarrhea in a canine |
US7998473B2 (en) | 2003-12-19 | 2011-08-16 | The Procter & Gamble Company | Methods of treatment or prevention of gastrointestinal disorders using canine probiotic bifidobacterium |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US8894991B2 (en) | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
US9821015B2 (en) | 2003-12-19 | 2017-11-21 | Mars, Incorporated | Methods of use of probiotic bifidobacteria for companion animals |
US8802158B2 (en) | 2003-12-19 | 2014-08-12 | The Iams Company | Methods of use of probiotic Lactobacilli for companion animals |
US8809035B2 (en) | 2003-12-19 | 2014-08-19 | The Iams Company | Canine probiotic Bifidobacterium |
US8840880B2 (en) | 2003-12-19 | 2014-09-23 | The Iams Company | Canine probiotic bifidobacteria globosum |
US7906112B2 (en) | 2003-12-19 | 2011-03-15 | The Procter & Gamble Company | Canine probiotic Lactobacilli |
US9580680B2 (en) | 2003-12-19 | 2017-02-28 | Mars, Incorporated | Canine probiotic bifidobacterium pseudolongum |
US8900569B2 (en) | 2003-12-19 | 2014-12-02 | The Iams Company | Method of treating diarrhea in a canine |
US9415083B2 (en) | 2004-05-10 | 2016-08-16 | Mars, Incorporated | Method for decreasing inflammation and stress in a mammal |
US9427000B2 (en) | 2005-05-31 | 2016-08-30 | Mars, Incorporated | Feline probiotic lactobacilli composition and methods |
US9192177B2 (en) | 2005-05-31 | 2015-11-24 | The Iams Company | Feline probiotic Lactobacilli |
US8034601B2 (en) | 2005-05-31 | 2011-10-11 | The Procter & Gamble Company | Feline probiotic bifidobacteria |
US9404162B2 (en) | 2005-05-31 | 2016-08-02 | Mars, Incorporated | Feline probiotic bifidobacteria and methods |
WO2008064893A1 (en) * | 2006-12-01 | 2008-06-05 | Organobalance Gmbh | Compositions, kits and uses for protecting the skin against pathogenic microorganisms |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US10709156B2 (en) | 2008-07-07 | 2020-07-14 | Mars, Incorporated | Pet supplement and methods of making |
US9210945B2 (en) | 2009-07-31 | 2015-12-15 | The Iams Company | Animal food having low water activity |
US9173423B2 (en) | 2009-07-31 | 2015-11-03 | The Iams Company | Animal food kibble with electrostatically adhered dusting |
US8691303B2 (en) | 2009-07-31 | 2014-04-08 | The Iams Company | Dusted animal food |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
US11154077B2 (en) | 2009-07-31 | 2021-10-26 | Mars, Incorporated | Process for dusting animal food |
US11304428B2 (en) | 2015-02-16 | 2022-04-19 | Mars, Incorporated | Interlocking kibble |
US11388914B2 (en) | 2015-04-28 | 2022-07-19 | Mars, Incorporated | Process of preparing a wet pet food, wet pet food produced by the process and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
GB9318439D0 (en) | 1993-10-20 |
AU7465794A (en) | 1995-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2021141899A (en) | Feed additive composition | |
US9011836B2 (en) | Methods of treating pigs with Bacillus strains | |
WO1995007090A1 (en) | Probiotics | |
WO1989005849A1 (en) | Lactic acid bacteria for use in fermented milk products and veterinary compositions | |
TW201234976A (en) | Feed additive composition | |
RU2412612C1 (en) | Method for production of "ferm km" probiotic fodder additive for domestic animals and birds | |
JP2008543290A (en) | Probiotic health and health foods, food and / or drinking water additives and uses thereof | |
JP4073922B2 (en) | Feed composition containing bifidobacteria growth promoting component and method of use | |
JPH10330274A (en) | Administration of live bacterial agent for birds | |
WO1994011492A1 (en) | Method of favorably modifying poultry intestinal microflora | |
EP0299183A2 (en) | Method for increasing the protein contents of milk in ruminants | |
RU2652836C1 (en) | Fodder additive with probiotic activity for farm animals, birds, horses and fish | |
JPH0616681B2 (en) | Animal feed additive, feed containing the same, and method for improving animal growth | |
RU2458526C1 (en) | Probiotic fodder additive for farm birds and fur animals | |
WO1993014187A1 (en) | A bacterial strain of the species bacillus coagulans: its use as a probiotic agent | |
JPWO2005087240A1 (en) | Antidiarrheal agent for livestock and poultry | |
KR100923226B1 (en) | The composition of improved Lactic acid bacteria feed additive and Method for manufacturing thereof | |
US20140037605A1 (en) | Anticoccidial composition | |
RU2652835C1 (en) | Method of productivity increasing and offspring preservation in pig breeding (options) | |
CN103919816B (en) | A kind of compound probiotic spray for preventing and treating newborn scouring and preparation method thereof | |
AU1365392A (en) | Feed additive and method | |
CN111084155A (en) | Healthy breeding method for effectively preventing and controlling swine fever | |
CN102754733A (en) | Novel micro-ecologic preparation for pig and preparation method thereof | |
Ovcharova et al. | Effect of the probiotic Lactobacillus reuteri on the immune status of piglets after weaning. | |
FI112374B (en) | Method for the administration of direct-fed microorganisms to poultry in ovo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KE KG KP KR KZ LK LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |